Top Ten Equity Holdings and Exposures

RNS Number : 9777I
Polar Capital Global Health Tst PLC
06 April 2020
 

6th April 2020

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st March 2020 and full portfolio listing as at 28th February 2020 available from the company's website

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 28th February 2020 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings 

%

Roche

6.4%

Bristol Myers Squibb

5.1%

Novo Nordisk A/S

4.8%

Merck & Co

4.7%

AbbVie

4.4%

Sanofi

4.1%

Bio-Rad Laboratories

3.9%

Becton Dickinson

3.9%

Fresenius Medical Care AG & Co

3.8%

Centene Corp

3.6%

Total

44.7%

 

 

Sector Exposure

%

Pharmaceuticals

35.5%

Biotechnology

22.9%

Healthcare Equipment

18.2%

Life Sciences Tools & Services

11.3%

Managed Healthcare

7.7%

Healthcare Services

7.2%

Healthcare Facilities

3.1%

Healthcare Technology

1.9%

Healthcare Supplies

1.2%

Healthcare Distributors

0.9%

Cash

-9.8%

Total

100.0%

 

 

Geographic Exposure

%

United States

73.5%

Denmark

8.6%

Switzerland

6.4%

France

4.1%

Germany

3.8%

Spain

3.1%

Belgium

3.1%

United Kingdom

2.8%

Japan

2.0%

Canada

1.8%

Netherlands

0.7%

Cash

-9.8%

Total

100.0%

 

 

 

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 10.2%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.co m

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement .


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUUPUQCCUPUGRQ
UK 100

Latest directors dealings